SCHEMBL7608527

SCHEMBL7608527

CCCOCCn1c(=O)c2c(ncn2Cc2ccccc2)n(CCC)c1=O

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
HIF1A Q16665 1/20 0.59
ADORA2B P29275 5/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
RXFP1 Q9HBX9 1/20 0.56
ALDH1A1 P00352 1/20 0.55
ADORA2A P29274 5/20 0.55
PDE1A P54750 1/20 0.54
PDE1B Q01064 1/20 0.54
PDE1C Q14123 1/20 0.54
KMT2A Q03164 4/20 0.54
MEN1 O00255 3/20 0.54
ADORA3 P0DMS8 1/20 0.51
ADORA1 P30542 1/20 0.51
PDE4A P27815 3/20 0.50
PDE4B Q07343 3/20 0.50
PDE4C Q08493 3/20 0.50
PDE4D Q08499 3/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1944712 0.91 POLB (0.70) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL7603086 0.86 KMT2A (0.62) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL7606543 0.86 POLB (0.57) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL1947176 0.85 KMT2A (0.71) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL7605727 0.85 KMT2A (0.55) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL1946890 0.84 POLB (0.67) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL3106268 0.83 LMNA (0.58) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL7604892 0.82 KMT2A (0.61) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL7606356 0.81 PDE1A (0.67) POLBHIF1AADORA2BSMN1; SMN2RXFP1
SCHEMBL3615415 0.81 ALDH1A1 (0.63) POLBHIF1AADORA2BSMN1; SMN2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed